Medication decisions - Right and wrong

Medical Care Research and Review

Volumn 59, Issue 2, 2002, Pages 123-145

  Stuart, Bruce ^a   Briesacher, Becky ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELECOXIB; CITALOPRAM; DIURETIC AGENT; ESTROGEN; FIBRINOLYTIC AGENT; HYPOCHOLESTEROLEMIC AGENT; MIVACURIUM; PSYCHOTROPIC AGENT; WARFARIN;

ADULT; AGED; DRUG COST; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG USE; GERIATRIC CARE; HEALTH INSURANCE; HIGH RISK POPULATION; HUMAN; MEDICAL DECISION MAKING; PRESCRIPTION; REVIEW; RISK FACTOR; VALIDATION PROCESS;

AGED; CLINICAL TRIALS; DECISION MAKING; DRUG INDUSTRY; DRUG THERAPY; HEALTH SERVICES RESEARCH; HUMANS; MEDICATION ERRORS; NORTH AMERICA; PATIENT COMPLIANCE; SOCIAL RESPONSIBILITY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0036094578     PISSN: 10775587     EISSN: None     Source Type: Journal    
DOI: 10.1177/1077558702059002001     Document Type: Review

References (77)

1. Survey on prescription drug issues and usage among Americans aged 50 and older
2. Medication use and the elderly: Current status and opportunities
3. Principles of pharmacology
4. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction
5. Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians
6. Explicit criteria for determining potentially inappropriate medication use by the elderly
7. Aging as a risk factor for medication-related problems
8. Inappropriate medication prescribing in skilled-nursing facilities
9. Explicit criteria for determining inappropriate medication use in nursing homes
10. Characteristics of the SAGE database: Anew resource for research on outcomes in long-term care
11. Characterization of geriatric drug-related hospital readmissions
12. Drug doverage and drug purchases by Medicare beneficiaries with hypertension
13. Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatients
14. Drug use and prescribing problems in the community-dwelling elderly: A study of three state Medicaid programs
15. Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure: Effect of physician specialty and patient characteristics
16. Access to health care. Part 3: Older adults
17. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly
18. Predictors of medication noncompliance in a sample of older adults
19. Adverse drug reaction-related hospitalizations of nursing facility patients: A 4-year study
20. Prescription drug coverage, utilization, and spending among Medicare beneficiaries
21. Surveillance for morbidity and mortality among older adults - United States, 1995-1996
22. Drug-drug interactions related to hospital admissions in older adults: A prospective study of 1000 patients
23. The effect of prescribed daily dose frequency on patient medication compliance
24. Drug-related morbidity and mortality: Updating the Cost-of-Illness Model
25. Inappropriate medication prescribing in homebound older adults
26. Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?
27. Prescription drug formularies in managed care: Concerns for the elderly population
28. Suboptimal medication use in the elderly: The tip of the iceberg
29. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy
30. Incidence and preventability of adverse drug events in nursing homes
31. Medicare beneficiaries' management of capped prescription benefits
32. Drug-related morbidity and mortality: A Cost-of-Illness Model
33. Similarity as a risk factor in drug-name confusion errors: The Look-Alike (Orthographic) and Sound-Alike (Phonetic) Model
34. Time trends in the use of cholesterol-lowering agents in older adults
35. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing: A randomized trial
36. Compliance with antihypertensive therapy among elderly Medicaid enrollees: The role of age, gender and race
37. Improving prescribing patterns for the elderly through an online drug utilization review intervention
38. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly
39. Managing pain in the elderly
40. A database analysis of potentially inappropriate drug use in an elderly Medicaid population
41. Medicare beneficiaries and drug coverage
42. The management of geriatric hypertension in health maintenance organizations
43. Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992
44. Psychotropic drugs and injuries among the elderly: A review
45. Evaluating drugs after their approval for clinical use
46. The treatment of unrelated disorders in patients with chronic medical diseases
47. How the elderly fare in HMOs: Outcomes from the Medicare competition demonstrations
48. Age and gender-related use of low dose drug therapy: The need to manufacture "senior" doses and to evaluate the minimal effective dosage
49. Optimising drug treatment for elderly people: The prescribing cascade
50. Prescribing for elderly persons
51. Financial barriers to medication use among the elderly
52. Appropriateness of medication prescribing in ambulatory elderly patients
53. Managed care co-pays: Higher and higher; more HMOs and pharmacy benefit managers using three-tier cost-control measures
54. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995
55. Toxicity of nonsteroidal anti-inflammatory drugs in the elderly: Is advanced age a risk factor?
56. Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for-service insurance
57. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes
58. Prescription drug costs for Medicare beneficiaries: Coverage and health status matter
59. Inappropriate medication use in community-residing older persons
60. General and psychotherapeutic medication use in 878 nursing facilities: A 1997 national survey
61. Do open formularies increase access to clinically useful drugs?
62. Inappropriate drug prescribing for the community-dwelling elderly
63. Medication use in residential care facilities for the elderly
64. Prevalence of potentially inappropriate drug use in the elderly Maryland Medicaid population